Integrated Strategies to Prevent Intradialytic Hypotension (The DialHypot Study)
DialHypot
1 other identifier
interventional
60
1 country
1
Brief Summary
The present study is aimed at comparing different strategies of UF profiling, dialysate sodium individualization and sodium profiling (even combining one with the other) and at evaluating the effectiveness of a new UF profile which has an ascending/descending shape. The goal of the study is to provide better dialysis tolerance and lower rates of intradialytic hypotensive events by the application of this UF profile design in combination with a neutral sodium balance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 7, 2019
CompletedFirst Posted
Study publicly available on registry
May 14, 2019
CompletedStudy Start
First participant enrolled
June 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2021
CompletedMay 16, 2019
May 1, 2019
2 years
May 7, 2019
May 14, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Occurrence of intradialytic hypotensive episodes (number of episodes within every HD session and time interval from HD start)
Hypotensive events and symptoms (headache, cramps, nausea and vomiting) will be recorded and analyzed as both number of occurrences and time of occurrence from the beginning of the HD session. IDH will be defined as follows: * "symptomatic IDH": decrease in SBP ≥ 20 mmHg or in MAP ≥ 10 mmHg associated with symptoms (KDIGO definition) * "asymptomatic IDH": drop in BP (SBP ≥ 20 mmHg or MAP ≥ 10 mmHg) within a 20 minutes interval, regardless of symptoms * for patients whose SBP is \< 100 mmHg at the beginning of treatment, the investigators will consider as IDH any decrease of SBP ≥ 10%
Within each dialysis session from the time of enrolment to the end of each study phase (9-11 weeks)
Secondary Outcomes (2)
Achievement of UF
Within each dialysis session from the time of enrolment to the end of each study phase (9-11 weeks)
Dialysis dose
Within each dialysis session from the time of enrolment to the end of each study phase (9-11 weeks)
Study Arms (3)
Linear descending UF profile
EXPERIMENTAL2-step descending Na profile, linear descending UF profile 3 weeks (9 sessions)
Run-in & washout phases
EXPERIMENTALconstant Na concentration, constant UF rate 3 weeks (6+3 sessions)
Ascending/descending UF profile
EXPERIMENTAL2-step descending Na profile, ascending/descending UF profile 3 weeks (9 sessions)
Interventions
Modulation of UF and dialysate sodium
Eligibility Criteria
You may qualify if:
- written informed consent
- age ≥ 18 years
- thrice weekly HD regimen for more than 6 months
- "hypotension-prone patients": ≥ 3 episodes of IDH in the month preceding the run-in phase of the study
You may not qualify if:
- IDWG \< 1.4% of dry weight (corresponding to \< 1 kg in a 70-kg person)
- twice weekly HD regimen
- residual daily urine output \> 300 mL
- active acute disease or hospitalization in the 8 weeks preceding the run-in phase
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Parma - UO Nefrologia AOU
Parma, Italy
Related Publications (1)
Peyronel F, Parenti E, Fenaroli P, Benigno GD, Rossi GM, Maggiore U, Fiaccadori E. Integrated strategies to prevent intradialytic hypotension: research protocol of the DialHypot study, a prospective randomised clinical trial in hypotension-prone haemodialysis patients. BMJ Open. 2020 Jul 8;10(7):e036893. doi: 10.1136/bmjopen-2020-036893.
PMID: 32641335DERIVED
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- University Professor
Study Record Dates
First Submitted
May 7, 2019
First Posted
May 14, 2019
Study Start
June 1, 2019
Primary Completion
June 1, 2021
Study Completion
June 1, 2021
Last Updated
May 16, 2019
Record last verified: 2019-05
Data Sharing
- IPD Sharing
- Will not share